Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Common Equity: 2010-2024

Historic Common Equity for Alkermes (ALKS) over the last 15 years, with Dec 2024 value amounting to $1.5 billion.

  • Alkermes' Common Equity rose 34.16% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 34.16%. This contributed to the annual value of $1.5 billion for FY2024, which is 21.81% up from last year.
  • Per Alkermes' latest filing, its Common Equity stood at $1.5 billion for FY2024, which was up 21.81% from $1.2 billion recorded in FY2023.
  • In the past 5 years, Alkermes' Common Equity ranged from a high of $1.5 billion in FY2024 and a low of $1.0 billion during FY2022.
  • Its 3-year average for Common Equity is $1.2 billion, with a median of $1.2 billion in 2023.
  • In the last 5 years, Alkermes' Common Equity decreased by 6.19% in 2022 and then increased by 21.81% in 2024.
  • Yearly analysis of 5 years shows Alkermes' Common Equity stood at $1.1 billion in 2020, then climbed by 4.27% to $1.1 billion in 2021, then declined by 6.19% to $1.0 billion in 2022, then increased by 15.23% to $1.2 billion in 2023, then rose by 21.81% to $1.5 billion in 2024.